Immunotherapy in Cholangiocarcinoma: Why It Works for Some Patients
Why Immunotherapy Works in Cholangiocarcinoma | dMMR, MSI & Survival
How We Win: The Three Survival Disciplines
The three cholangiocarcinoma survival disciplines help patients navigate bile duct cancer with clarity, right action and perseverance.
Cholangiocarcinoma Survival System
Cholangiocarcinoma survival depends on more than treatment. Discover the system built to help patients navigate the full cancer journey.
Cholangiocarcinoma Diagnosis Mistakes That Quietly Cost Patients Their Best Chance
If you are newly diagnosed with cholangiocarcinoma, the first decisions matter. This guide explains the common mistakes that quietly reduce treatment options and how to avoid them.
Mandy Wallace
Mandy Wallace, a perihilar cholangiocarcinoma survivor, shares how rapid diagnosis, major liver surgery and disciplined follow up led to 12 years well.
Beth Ivimey
Beth Ivimey’s cholangiocarcinoma journey began with an incidental diagnosis and progressed through systemic therapy, molecular profiling and clinical trial treatment. Her story reflects how modern care evolves when surgery is not possible.
Immunotherapy in Cholangiocarcinoma: Why It Works for Some Patients
Why Immunotherapy Works in Cholangiocarcinoma | dMMR, MSI & Survival
How We Win: The Three Survival Disciplines
The three cholangiocarcinoma survival disciplines help patients navigate bile duct cancer with clarity, right action and perseverance.
Cholangiocarcinoma Survival System
Cholangiocarcinoma survival depends on more than treatment. Discover the system built to help patients navigate the full cancer journey.
Cholangiocarcinoma Diagnosis Mistakes That Quietly Cost Patients Their Best Chance
If you are newly diagnosed with cholangiocarcinoma, the first decisions matter. This guide explains the common mistakes that quietly reduce treatment options and how to avoid them.
Mandy Wallace
Mandy Wallace, a perihilar cholangiocarcinoma survivor, shares how rapid diagnosis, major liver surgery and disciplined follow up led to 12 years well.
Beth Ivimey
Beth Ivimey’s cholangiocarcinoma journey began with an incidental diagnosis and progressed through systemic therapy, molecular profiling and clinical trial treatment. Her story reflects how modern care evolves when surgery is not possible.
